Detected ·
Biotia
$9M—
Biotia, a New York City-based infectious disease diagnostics company, announced an oversubscribed $9M financing (exceeding its previously announced Series A) led by CEO and co-founder Niamh B. O'Hara, with investors including Convergent Ventures, DigitalDx Ventures, Cloquet Capital Partners, and Continuum Health Ventures.
- Website
- www.biotia.io
- linkedin.com/company/biotia
- Amount
- $9 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-02 12:09:18 UTC
- Signal ID
- 885611bb-bb17-4461-b120-bdb09f2e366e
As the API returns it
{
"id": "885611bb-bb17-4461-b120-bdb09f2e366e",
"created_at": "2026-10-02T12:09:18.654489Z",
"company_name": "Biotia",
"company_website_url": "www.biotia.io",
"company_linkedin_url": "https://www.linkedin.com/company/biotia",
"event_type": "funding",
"funding_amount": 9000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Biotia, a New York City-based infectious disease diagnostics company, announced an oversubscribed $9M financing (exceeding its previously announced Series A) led by CEO and co-founder Niamh B. O'Hara, with investors including Convergent Ventures, DigitalDx Ventures, Cloquet Capital Partners, and Continuum Health Ventures.*"
}